ask="N/A"
ask_size="N/A"
average_daily_volume="25119"
bid="N/A"
bid_size="N/A"
book_value="0.45"
change="-0.20"
change_from_200_day_moving_average="0.28"
change_from_50_day_moving_average="0.29"
change_from_52_week_high="-1.39"
change_From_52_week_low="2.13"
change_in_percent="-4.88%"
close="3.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-14.69M"
eps_estimate_current_year="-1.97"
eps_estimate_next_quarter="-0.02"
eps_estimate_next_year="-0.15"
ex_dividend_date="N/A"
float_shares="4889000"
high="4.10"
high_52_weeks="5.29"
last_trade_date="2/6/2017"
last_trade_price="3.90"
last_trade_size="261"
last_trade_time="4:02pm"
low="3.90"
low_52_weeks="1.77"
market_capitalization="59.02M"
moving_average_200_day="3.62"
moving_average_50_day="3.61"
name="NovaBay Pharmaceuticals
Inc. C"
notes="N/A"
one_year_target_price="7.50"
open="4.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+7.62%"
percent_change_from_50_day_moving_average="+7.90%"
percent_change_from_52_week_high="-26.28%"
percent_change_from_52_week_low="+120.34%"
previous_close="4.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.07"
price_per_sales="6.56"
revenue="9.45M"
shares_outstanding="15134000"
short_ratio="6.07"
stock_exchange="ASE"
symbol="NBY"
volume="19229"
weeks_range_52="1.77 - 5.29"
